Racial disparities in the receipt of adjuvant chemotherapy in patients with resected stage I-III pancreatic adenocarcinoma.

被引:0
|
作者
Sanford, Nina Niu
Xu, Xiaohan
Sher, David J.
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[2] UT Southwestern, Dallas, TX USA
关键词
D O I
10.1200/JCO.2019.37.4_suppl.357
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
357
引用
收藏
页数:1
相关论文
共 50 条
  • [31] ASO Visual Abstract: Is There a Benefit to Adjuvant Chemotherapy in Resected, Early-Stage Pancreatic Ductal Adenocarcinoma?
    Kevin M. Turner
    Aaron M. Delman
    Allison M. Ammann
    Davendra Sohal
    Olugbenga Olowokure
    Kyuran A. Choe
    Milton T. Smith
    Jordan R. Kharofa
    Syed A. Ahmad
    Gregory C. Wilson
    Sameer H. Patel
    Annals of Surgical Oncology, 2022, 29 : 4622 - 4623
  • [32] ASO Visual Abstract: Is There a Benefit to Adjuvant Chemotherapy in Resected, Early-Stage Pancreatic Ductal Adenocarcinoma?
    Turner, Kevin M.
    Delman, Aaron M.
    Ammann, Allison M.
    Sohal, Davendra
    Olowokure, Olugbenga
    Choe, Kyuran A.
    Smith, Milton T.
    Kharofa, Jordan R.
    Ahmad, Syed A.
    Wilson, Gregory C.
    Patel, Sameer H.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (07) : 4622 - 4623
  • [33] Letter to the editor regarding: "Meta-analysis of adjuvant chemotherapy versus no adjuvant chemotherapy for resected stage I pancreatic cancer"
    Huang, Youbao
    SURGERY, 2025, 180
  • [34] Margin Clearance and Survival in Resected Pancreatic Adenocarcinoma in the Era of Adjuvant Chemotherapy
    Strobel, O.
    Hank, T.
    Hinz, U.
    Bergmann, F.
    Jaeger, D.
    Hackert, T.
    Buechler, M. W.
    PANCREAS, 2015, 44 (08) : 1417 - 1417
  • [35] The effect of antibiotic use on survival of patients with resected pancreatic ductal adenocarcinoma.
    Hasanov, Merve
    Mohindroo, Chirayu
    Rogers, Jane
    Prakash, Laura
    Overman, Michael J.
    Varadhachary, Gauri Rajani
    Wolff, Robert A.
    Javle, Milind M.
    Fogelman, David R.
    Pant, Shubham
    Katz, Matthew H. G.
    Kim, Michael Paul
    Tzeng, Ching-Wei David
    McAllister, Florencia
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [36] Adjuvant Chemotherapy Is Beneficial in Stage III Ampullary Adenocarcinoma
    Premji, Alykhan M.
    Donahue, Timothy R.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (03) : 512 - 514
  • [37] SURVIVAL IMPACT OF ADJUVANT CHEMOTHERAPY FOR RESECTED EARLY STAGE RECTAL ADENOCARCINOMA
    Tay, R.
    Jamnagerwalla, M.
    Steel, M.
    Wong, H. L.
    McKendrick, J. J.
    Faragher, I.
    Kosmider, S.
    Hastie, I.
    Desai, J.
    Harold, M.
    Gibbs, P.
    Wong, R.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 66 - 66
  • [38] NAMPT expression in stage I/II pancreatic ductal adenocarcinoma.
    Davis, Katelynn
    Dunseth, Craig
    Mott, Sarah L.
    Bellizzi, Andrew
    Chan, Carlos Hou Fai
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] Disparities in Receipt of Adjuvant Therapy After Upfront Surgical Resection for Pancreatic Ductal Adenocarcinoma
    Roi Anteby
    Lawrence S. Blaszkowsky
    Theodore S. Hong
    Motaz Qadan
    Annals of Surgical Oncology, 2023, 30 : 2473 - 2481
  • [40] Evaluation of the Significance of Adjuvant Chemotherapy in Patients With Stage IA Pancreatic Ductal Adenocarcinoma
    Izumo, W.
    Higuchi, R.
    Yamamoto, M.
    PANCREAS, 2021, 50 (07) : 1068 - 1068